vs

Side-by-side financial comparison of Dexcom (DXCM) and Western Union CO (WU). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $982.7M, roughly 1.3× Western Union CO). Dexcom runs the higher net margin — 21.2% vs 6.6%, a 14.6% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 0.0%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -1.9%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

The Western Union Company is an American multinational financial services corporation headquartered in Denver, Colorado.

DXCM vs WU — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.3× larger
DXCM
$1.3B
$982.7M
WU
Growing faster (revenue YoY)
DXCM
DXCM
+21.6% gap
DXCM
21.6%
0.0%
WU
Higher net margin
DXCM
DXCM
14.6% more per $
DXCM
21.2%
6.6%
WU
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
-1.9%
WU

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
DXCM
DXCM
WU
WU
Revenue
$1.3B
$982.7M
Net Profit
$267.3M
$64.7M
Gross Margin
62.9%
Operating Margin
25.6%
12.5%
Net Margin
21.2%
6.6%
Revenue YoY
21.6%
0.0%
Net Profit YoY
153.6%
-47.6%
EPS (diluted)
$0.67
$0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
WU
WU
Q1 26
$1.3B
$982.7M
Q4 25
$1.3B
$972.0M
Q3 25
$1.2B
$985.3M
Q2 25
$1.2B
$983.6M
Q1 25
$1.0B
$938.7M
Q4 24
$1.1B
$1.0B
Q3 24
$994.2M
$993.4M
Q2 24
$1.0B
$1.0B
Net Profit
DXCM
DXCM
WU
WU
Q1 26
$267.3M
$64.7M
Q4 25
$267.3M
$114.4M
Q3 25
$283.8M
$139.6M
Q2 25
$179.8M
$122.1M
Q1 25
$105.4M
$123.5M
Q4 24
$151.7M
$385.7M
Q3 24
$134.6M
$264.8M
Q2 24
$143.5M
$141.0M
Gross Margin
DXCM
DXCM
WU
WU
Q1 26
62.9%
Q4 25
62.9%
33.6%
Q3 25
60.5%
34.7%
Q2 25
59.5%
34.6%
Q1 25
56.9%
34.0%
Q4 24
58.9%
35.0%
Q3 24
59.7%
34.2%
Q2 24
62.4%
35.0%
Operating Margin
DXCM
DXCM
WU
WU
Q1 26
25.6%
12.5%
Q4 25
25.6%
19.1%
Q3 25
20.1%
20.5%
Q2 25
18.4%
19.6%
Q1 25
12.9%
18.9%
Q4 24
17.0%
17.5%
Q3 24
15.3%
16.6%
Q2 24
15.7%
18.7%
Net Margin
DXCM
DXCM
WU
WU
Q1 26
21.2%
6.6%
Q4 25
21.2%
11.8%
Q3 25
23.5%
14.2%
Q2 25
15.5%
12.4%
Q1 25
10.2%
13.2%
Q4 24
13.6%
37.9%
Q3 24
13.5%
26.7%
Q2 24
14.3%
13.8%
EPS (diluted)
DXCM
DXCM
WU
WU
Q1 26
$0.67
$0.41
Q4 25
$0.67
$0.36
Q3 25
$0.70
$0.43
Q2 25
$0.45
$0.37
Q1 25
$0.27
$0.36
Q4 24
$0.37
$1.14
Q3 24
$0.34
$0.78
Q2 24
$0.35
$0.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
WU
WU
Cash + ST InvestmentsLiquidity on hand
$917.7M
$909.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$910.5M
Total Assets
$6.3B
$8.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
WU
WU
Q1 26
$917.7M
$909.2M
Q4 25
$917.7M
$1.2B
Q3 25
$1.8B
$947.8M
Q2 25
$1.2B
$1.0B
Q1 25
$904.9M
$1.3B
Q4 24
$606.1M
$1.5B
Q3 24
$621.2M
$1.1B
Q2 24
$939.2M
$1.0B
Total Debt
DXCM
DXCM
WU
WU
Q1 26
Q4 25
$2.9B
Q3 25
$2.5B
Q2 25
$2.5B
Q1 25
$2.5B
Q4 24
$3.0B
Q3 24
$2.1B
Q2 24
$2.1B
Stockholders' Equity
DXCM
DXCM
WU
WU
Q1 26
$2.7B
$910.5M
Q4 25
$2.7B
$957.8M
Q3 25
$2.7B
$925.4M
Q2 25
$2.6B
$883.6M
Q1 25
$2.3B
$939.4M
Q4 24
$2.1B
$968.9M
Q3 24
$2.0B
$652.7M
Q2 24
$2.4B
$440.8M
Total Assets
DXCM
DXCM
WU
WU
Q1 26
$6.3B
$8.1B
Q4 25
$6.3B
$8.3B
Q3 25
$7.5B
$7.8B
Q2 25
$7.3B
$8.0B
Q1 25
$6.8B
$8.3B
Q4 24
$6.5B
$8.4B
Q3 24
$6.4B
$7.7B
Q2 24
$6.8B
$8.0B
Debt / Equity
DXCM
DXCM
WU
WU
Q1 26
Q4 25
3.01×
Q3 25
2.70×
Q2 25
2.83×
Q1 25
2.61×
Q4 24
3.04×
Q3 24
3.29×
Q2 24
4.88×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
WU
WU
Operating Cash FlowLast quarter
$109.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
4.8%
Cash ConversionOCF / Net Profit
1.68×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
WU
WU
Q1 26
$109.0M
Q4 25
$294.0M
$135.4M
Q3 25
$659.9M
$260.4M
Q2 25
$303.0M
$-300.0K
Q1 25
$183.8M
$148.2M
Q4 24
$301.4M
$134.0M
Q3 24
$199.5M
$212.1M
Q2 24
$279.4M
$-33.8M
Free Cash Flow
DXCM
DXCM
WU
WU
Q1 26
Q4 25
$192.1M
$115.5M
Q3 25
$579.4M
$252.7M
Q2 25
$208.9M
$-7.8M
Q1 25
$96.8M
$144.8M
Q4 24
$176.8M
$119.7M
Q3 24
$88.3M
$205.1M
Q2 24
$213.3M
$-38.9M
FCF Margin
DXCM
DXCM
WU
WU
Q1 26
Q4 25
15.3%
11.9%
Q3 25
47.9%
25.6%
Q2 25
18.1%
-0.8%
Q1 25
9.3%
15.4%
Q4 24
15.9%
11.8%
Q3 24
8.9%
20.6%
Q2 24
21.2%
-3.8%
Capex Intensity
DXCM
DXCM
WU
WU
Q1 26
4.8%
Q4 25
8.1%
2.0%
Q3 25
6.7%
0.8%
Q2 25
8.1%
0.8%
Q1 25
8.4%
0.4%
Q4 24
11.2%
1.4%
Q3 24
11.2%
0.7%
Q2 24
6.6%
0.5%
Cash Conversion
DXCM
DXCM
WU
WU
Q1 26
1.68×
Q4 25
1.10×
1.18×
Q3 25
2.33×
1.87×
Q2 25
1.69×
-0.00×
Q1 25
1.74×
1.20×
Q4 24
1.99×
0.35×
Q3 24
1.48×
0.80×
Q2 24
1.95×
-0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons